Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01144104 · ClinicalTrials.gov registry record · NA

Activating Messages for Enhancing Primary Care Practice (AMEP2): Effectiveness Study

A NA study of Depression, sponsored by University of California, Davis.

Completed
Registry status
NA
Development phase
925
Enrollment target
6
Study locations

NCT01144104: Completed NA study of Depression, sponsored by University of California, Davis.

NCT01144104 is a NA study of Depression that has completed, run by University of California, Davis. The registered enrollment target is 925 participants, above the 785-participant average among 679 other Depression trials with a reported enrollment target (18% higher). The trial reports 6 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01144104, a NA study of Depression, has completed, sponsored by University of California, Davis.

COMPLETED
Registry status
NA
Development phase
925 participants
Enrollment target
6
Study locations

Study Summary

This trial consists of two linked substudies. Substudy 1: Activating Messages for Enhancing Primary Care Practice (AMEP2): Effectiveness Study Substudy 2: Activating Messages for Enhancing Primary Care Practice (AMEP2): Toxicity Study The purpose of the Effectiveness Study is to assess the comparative effectiveness of three multimedia educational interventions (a targeted educational video, a tailored interactive multimedia computer program, and an "attention control") for increasing the likelihood that primary care patients with significant depressive symptoms will seek appropriate care (n = 510). The primary study outcomes are provision of minimally acceptable initial care, reductions in depression-related stigma, and improvement in depression symptoms. (See Process of Care and Patient Outcomes in Primary Outcome Measure section.) The purpose of the Toxicity Study is to assess the potential benefits (reduced stigma) and harms (inappropriate prescribing) associated with three multimedia depression educational interventions when administered to patients with few or no depressive symptoms (n = 308). The primary outcomes relating to this outcome are reducing depression-related stigma and reducing unnecessary prescribing. (See Toxicity in Primary Outcome Measure section.) Both studies will look at the secondary outcome measure of patient requests for depression treatment.

Primary Outcome

Minimally acceptable initial care, meaning 1) antidepressant prescription, 2) referral to a mental health specialist, or 3) follow up within 14 days if PHQ \>= 15 or within 30 days otherwise

Conditions Studied

Interventions

  • BEHAVIORAL Public Service Announcement
  • BEHAVIORAL Interactive Multi-Media Computer Program
  • BEHAVIORAL Sleep Hygiene Video

Study Locations (6)

California

  • Sutter Health - Elk Grove Family Medicine - Elk Grove
  • VA Northern California Healthcare System - Mather
  • Kaiser Permanente - Point West - Sacramento
  • University of California, Davis - Sacramento
  • San Francisco VA Medical Center - San Francisco
  • University of California, San Francisco - San Francisco

Trial Details

FieldValue
Enrollment Target 925 participants
Start Date 2010-06
Est. Completion 2014-06
Phase NA
University of California, Davis

657 total trials

What the finished NCT01144104 record still lists

NCT01144104 is an interventional study that assigns participants to a tested intervention. The registered 925 participants enrollment target is mid-sized for trials with a published cap, above the 785-participant average among 679 other Depression trials with a reported enrollment target (18% higher).

The record links to 1 condition, with Depression appearing as the primary indexed condition, and to 3 interventions - of which Public Service Announcement is the first listed.

NCT01144104 lists 6 locations in 1 state (California).

Frequently Asked Questions

What is clinical trial NCT01144104 about?

NCT01144104 is a clinical study titled "Activating Messages for Enhancing Primary Care Practice (AMEP2): Effectiveness Study". This trial consists of two linked substudies. Substudy 1: Activating Messages for Enhancing Primary Care Practice (AMEP2): Effectiveness Study Substudy 2: Activating Messages for Enhancing Primary Care Practice (AMEP2): Toxicity Study The purpose of the Effectiveness Study is to assess the compar...

What is the current status of trial NCT01144104?

This trial is currently completed. It is a NA study. The enrollment target is 925 participants. The study started on 2010-06. Estimated completion is 2014-06.

What conditions does trial NCT01144104 study?

This clinical trial studies the following conditions: Depression.

What interventions are being tested in trial NCT01144104?

The interventions under investigation include: Public Service Announcement (BEHAVIORAL), Interactive Multi-Media Computer Program (BEHAVIORAL), Sleep Hygiene Video (BEHAVIORAL).

Who is sponsoring clinical trial NCT01144104?

This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01144104 being conducted?

This trial has 6 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Depression

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT01144104's enrollment target sits among peer trials

925 45th of 679 higher than 635 of 679 other Depression trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Depression trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03995082 · 925 participants · NA

    Breast Cancer Patient Engagement With Patient Reported Outcome Measure Survey

  • NCT04692493 · 924 participants · Phase 3

    Ra-pro Pragmatic Trial

  • NCT05656807 · 924 participants · NA

    Evaluation of Child Care Staff Weight Management Program

  • NCT06082453 · 924 participants · NA

    Modernizing Perinatal Syphilis Testing

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01144104, the US trial registry maintained by the National Library of Medicine. NCT01144104 (mid enrollment · multi site footprint · completed) retrieved and formatted by PlainTrial, see methodology.